Nu Skin Enterprises

Nu Skin Enterprises, Inc. is a holding company, which engages in the development and distribution of personal care products and nutritional supplements. It operates through the following segments: Mainland China, Americas, South Korea, Southeast Asia/Pacific, EMEA, Japan, Hong Kong/Taiwan, Nu Skin Other, Manufacturing, Grow Tech, and Rhyz Other. The first seven segments represent the Nu Skin geographic operations. The last three segments deal with Rhyz investments. Its brands include Nu Skin and Pharmanex. The company was founded by Blake M. Roney, Sandra N. Tillotson, and Steven J. Lund in 1984 and is headquartered in Provo, UT.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Nu Skin Enterprises reports $2.23B revenue for 2022, focuses on innovation and social commerce

Nu Skin Enterprises navigated challenges in 2022, focusing on innovation and social commerce to drive revenue growth. The company aims to overcome challenges in 2023 and achieve Nu Vision 2025 goals through strategic initiatives. Nu Skin's emphasis on enhancing the iO experience and optimizing expenses positions it for sustainable value to investors.

Nu Skin Enterprises meets Q1 expectations, eyes growth in Asia

Nu Skin's Q1 performance in line with expectations, with notable success in key markets like South Korea and Mainland China.
Challenges persist in certain regions due to macroeconomic factors, necessitating strategic adjustments for sustained growth.
Opportunities lie in expanding TRMe program, leveraging digital initiatives, and driving operational improvements for long-term value creation.

Nu Skin reports robust Q2 earnings, eyes growth through acquisitions

Nu Skin Enterprises delivered strong Q2 results driven by Mainland China growth, with revenue of $500.3 million and EPS of $0.54. The company faces challenges in other markets due to macro-related pressures.
Strategic acquisitions of BeautyBio and LifeDNA aim to enhance Nu Skin's core business through personalization and technology. The company's focus on innovation and market trends presents growth opportunities.
With a clear strategic direction, Nu Skin is poised to navigate challenges, capitalize on opportunities, and drive continued growth in the beauty and wellness industry.

Nu Skin reports Q3 revenue of $499M, adjusts 2023 guidance

Nu Skin adjusts 2023 guidance, expecting revenue of $1.92B to $1.96B and EPS of negative $0.10 to $0.05. The company is streamlining expenses and maximizing cash flow.

Nu Skin surpasses Q4 revenue targets, eyes growth opportunities

Nu Skin Enterprises delivered strong Q4 results, exceeding revenue guidance and showcasing a focus on innovation and strategic growth initiatives.
Despite challenges in certain regions, the company demonstrated resilience and stability in key markets, laying the groundwork for future expansion and market penetration.
By rebalancing dividends for growth investments and prioritizing reinvestment in the business, Nu Skin is poised to capitalize on opportunities for market diversification and sustainable growth.
With a clear roadmap for 2024, including product launches, market entries, and capital reallocation strategies, Nu Skin is well-positioned to drive performance and enhance shareholder value.

Nu Skin Enterprises reports robust Q1 earnings, eyes global expansion

Nu Skin Enterprises showcased resilience in revenue and earnings, driven by strong performance in core and new business segments.
While facing challenges from macroeconomic factors, the company is strategically focused on innovation, cost efficiency, and market expansion.
Opportunities lie in product diversification, market entries, and sustainability efforts, positioning Nu Skin for future growth and market leadership.

Nu Skin surpasses Q2 revenue targets, eyes growth amid challenges

Nu Skin Enterprises delivered strong Q2 performance, exceeding revenue guidance and showcasing financial discipline. Despite challenges in China and FX pressures, the company remains focused on innovation and growth. Strategic investments in new products, markets, and brand awareness position Nu Skin for future success. Revised guidance reflects adaptability to market conditions and commitment to long-term vision.

Nu Skin Enterprises meets Q3 guidance, eyes India expansion

Nu Skin's Q3 performance reflects a balanced approach to addressing challenges and leveraging strengths.
Strategic initiatives to drive growth, optimize operations, and expand into new markets are key focus areas.
Despite market pressures, Nu Skin's focus on innovation and efficiency bodes well for future growth.
Overall, Nu Skin's financials and strategic direction indicate a resilient and forward-thinking company.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Nu Skin Enterprises, Inc. is a holding company, which engages in the development and distribution of beauty and wellness solutions. It operates through the following segments: Mainland China, Americas, South Korea, Southeast Asia/Pacific, EMEA, Japan, Hong Kong/Taiwan, Nu Skin Other, Manufacturing, and Rhyz Other. The company was founded by Blake M. Roney, Sandra N. Tillotson, and Steven J. Lund in 1984 and is headquartered in Provo, UT.

NU Skin Enterprises, Inc. (NYSE:NUS ) Q1 2023 Earnings Conference Call May 3, 2023 5:00 PM ET Company Participants Scott Pond - VP, IR Ryan Napierski - President, CEO & Director Connie Tang - EVP & Chief Global Growth & Customer Experience Officer James Thomas - Interim CFO Conference Call Participants Chasen Bender - Citi Operator Good day and thank you for standing by. Welcome to the Quarter One Nu Skin Enterprises Earnings Conference Call.

NU Skin Enterprises, Inc. (NUS) Q1 2023 Earnings Call Transcript

Nu Skin Enterprises (NUS) came out with quarterly earnings of $0.37 per share, beating the Zacks Consensus Estimate of $0.33 per share. This compares to earnings of $0.76 per share a year ago.

Nu Skin Enterprises (NUS) Beats Q1 Earnings and Revenue Estimates

Company Reiterates 2023 Guidance PROVO, Utah , May 3, 2023 /PRNewswire/ -- Nu Skin Enterprises, Inc. (NYSE: NUS) today announced first quarter 2023 results in line with expectations. Executive Summary Q1 2023 vs.

Nu Skin Enterprises Reports First Quarter 2023 Financial Results

Nu Skin's (NUS) first-quarter performance is likely to reflect macro headwinds like prolonged COVID-related disruptions, unfavorable currency rates and global inflation.

Factors to Consider Ahead of Nu Skin's (NUS) Q1 Earnings

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Is Nu Skin Enterprises (NUS) Stock Undervalued Right Now?

Nu Skin (NUS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Nu Skin Enterprises (NUS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Report highlights the global sustainability and social impact of the beauty and wellness brand  PROVO, Utah , April 19, 2023 /PRNewswire/ -- Nu Skin, a global leader in beauty and wellness, today released its 2022 Social Impact and Sustainability Report. The report outlines progress on the company's environmental, social and governance (ESG) priorities, including its sustainability commitments and global giving efforts.

Nu Skin Releases 2022 Social Impact and Sustainability Report

Nu Skin (NUS) benefits from its product launches and Nu Vision 2025 strategy amid challenges like cost inflation and currency volatility.

Nu Skin's (NUS) Nu Vision 2025 Strategy Bodes Well, Costs Hurt

The company showed strength in its business model despite decline in revenues. The Chinese economy is showing signs of recovery, and healthcare spending in the markets the company serves is still strong.

Nu Skin Is Here To Stay

Company to release Q1 results May 3 PROVO, Utah , March 30, 2023 /PRNewswire/ -- Nu Skin Enterprises, Inc. (NYSE: NUS) today announced the resignation of its chief financial officer, Mark Lawrence, effective March 31, 2023. After six years at the company, Lawrence has elected to pursue an outside opportunity but will remain as a senior advisor through April 2023 to support a smooth transition.

Nu Skin Enterprises Announces Resignation of CFO; Reiterates First Quarter and 2023 Outlook

Herbalife

Tupperware

USANA Health Sciences

This isn't your grandmother's environment for growing an MLM company. How long can Net Margins be sustained with declining Gross Margins and Operating Margins?

Multilevel Marketing: 2018 And Beyond?

Nu Skin (NUS) bears the brunt of COVID-related disruptions, unfavorable currency movements and global inflation.

Nu Skin (NUS) Hurt by Cost Inflation, Adverse Currency Movements

Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock?

Why Is Nu Skin (NUS) Down 9.2% Since Last Earnings Report?

Nu Skin's (NUS) fourth-quarter 2022 results reflect lower revenues and earnings on macro headwinds, continued inflation and unfavorable currency.

Nu Skin (NUS) Q4 Earnings Top Estimates, Sales Down Y/Y

Nu Skin (NUS) delivered earnings and revenue surprises of 67.92% and 3.94%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Nu Skin Enterprises (NUS) Q4 Earnings Surpass Estimates

NU Skin Enterprises, Inc. (NYSE:NUS ) Q4 2022 Earnings Conference Call February 15, 2023 5:00 PM ET Company Participants Scott Pond - VP, IR Ryan Napierski - President, CEO & Director Connie Tang - EVP & Chief Global Growth & Customer Experience Officer Mark Lawrence - EVP & CFO Conference Call Participants Mark Astrachan - Stifel, Nicolaus & Company Chasen Bender - Citigroup Operator Good day and thank you for standing by. Welcome to the Fourth Quarter 2022 Nu Skin Enterprises Earnings Conference Call.

NU Skin Enterprises, Inc. (NUS) Q4 2022 Earnings Call Transcript

Shares of Nu Skin Enterprises Inc. NUS, +4.76% dropped more than 9% in the extended session Wednesday after the multilevel marketing company reported mixed fourth-quarter results, beating Wall Street expectations for profit but missing on sales, and guidance also disappointed. Nu Skin earned $57.2 million, or $1.15 a share, in the quarter, swinging from a loss of $9.2 million, or 18 cents a share, in the year-ago quarter.

Nu Skin stock falls 9% after Q4 sales miss

Company Provides Initial Outlook for Q1 and FY 2023 PROVO, Utah , Feb. 15, 2023 /PRNewswire/ -- Nu Skin Enterprises, Inc. (NYSE: NUS) today announced fourth quarter and full year 2022 results. Executive Summary Q4 2022 vs.

Nu Skin Enterprises Reports Fourth Quarter and 2022 Financial Results

PROVO, Utah , Feb. 15, 2023 /PRNewswire/ -- Nu Skin Enterprises, Inc. (NYSE: NUS) today announced its board of directors has increased the quarterly cash dividend to $0.39 per share, which will be paid on March 8, 2023, to shareholders of record on Feb. 27, 2023. "This marks the 22nd consecutive year of paying and increasing our dividend, demonstrating our confidence in the long-term direction of the company and the strong commitment of returning value to our shareholders by leveraging our healthy financial position," said Mark Lawrence, Nu Skin chief financial officer.

Nu Skin Enterprises Announces Dividend Increase for 22nd Consecutive Year

Nu Skin's (NUS) fourth-quarter results are likely to reflect the adverse impacts of cost inflation and currency translations, whereas a focus on the Nu Vision 2025 strategy is likely to have been an upside.

Nu Skin (NUS) Readies for Q4 Earnings: Everything to Note

PROVO, Utah , Jan. 11, 2023 /PRNewswire/ -- Nu Skin Enterprises, Inc. (NYSE: NUS), a leading beauty and wellness company, today announced it has reached the milestone of providing 800 million meals for children since 2002 through its Nourish the Children (NTC) initiative. Malnourished children in more than 65 countries around the world have been fed VitaMeal,* a nutrient-dense food, from one of NTC's third-party charity partners after Nu Skin sales leaders, customers or employees purchase and donate bags of food.

Nu Skin Reaches 800 Million Meals Purchased and Donated in its Fight Against Child Malnutrition

PROVO, Utah , Jan. 9, 2023 /PRNewswire/ -- Nu Skin Enterprises, Inc. (NYSE: NUS) today announced it will release fourth quarter and full year 2022 results after the market closes on Wednesday, Feb. 15. The Nu Skin management team will host a conference call with the investment community later that same day at 5 p.m.

Nu Skin Enterprises to Announce Fourth Quarter and 2022 Financial Results

Our residual valuation model suggests that Nu Skin is overvalued by approximately 50%. Despite re-openings in China, Nu Skin's operations remain exposed to cyclical risks.

Nu Skin: 50% Downside Is Possible In 2023

PROVO, Utah , Dec. 12, 2022 /PRNewswire/ -- Nu Skin Enterprises (NYSE: NUS), a leader in beauty and wellness, today announced its participation in this week's 76th Annual Scientific Meeting & Showcase of the Society of Cosmetic Chemists in Los Angeles. The premier conference for cosmetic science education is bringing together more than 1,000 people to discuss the latest research in the cosmetics and personal care industry.

News for Nu Skin Enterprises Stock (NUS)